TRISORALEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trisoralen, and what generic alternatives are available?
Trisoralen is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in TRISORALEN is trioxsalen. There are two drug master file entries for this compound. Additional details are available on the trioxsalen profile page.
Summary for TRISORALEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 3,551 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRISORALEN at DailyMed |
US Patents and Regulatory Information for TRISORALEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharm Intl | TRISORALEN | trioxsalen | TABLET;ORAL | 012697-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |